Effects of Captopril on Metabolic Mechanism of Endogenous NOS Inhibitor in Human Umbilical Vein Endothelial Cell Induced by Oxidized Low Density Lipoprotein

夏子荣,万磊,李菊香,颜素娟,苏海,罗伟,程晓曙
DOI: https://doi.org/10.3969/j.issn.1001-1439.2007.02.019
2007-01-01
Journal of Clinical Cardiology
Abstract:Objective:To observe the effects of oxidized low density lipoprotein (ox-LDL) on dimethylarginine dimethylaminohydrolase (DDAH) activity and concentration of human umbilical vein endothelial cells (HUVECs), and investigate the metabolic mechanism of endogenous NOS inhibitor and the effect of captopril. Method:HUVECs of 3-6 th passage, cultured with modified Jaffes’ method, were divided into three groups:①cells cultured with equivalent DMEM medium as control group; ②ox-LDL intervention group, 100,150 mg/L oxLDL were added respectively; ③drug intervention group: 150 mg/L ox-LDL and 100 mg/L captopril were added. ADMA, nitric oxide (NO), endothim (ET), L-citorulline (L-cit) concentrations and the activity of NOS in the medium were measured after 24 h exposure. ADMA concentration in the medium was determined by high-performance liquid chromatography. Western blotting was performed to evaluate DDAH expression. Result:Compared with control group, ADMA and ET concentrations were increased, while the level of NO and the activity of NOS decreased and relevant to the concentrations of ox-LDL. We assayed DDAH activity by determining L-cit formation from ADMA. The concentration of L-cit was decreased, while the DDAH expression had no obvious change. In the captopril inter vention group, ADMA, ET concentrations were decreased, while the level of NO, L-cit and the activity of NOS increased. Conclusion:Endothelial dysfunction induced by ox-LDL is associated with the increase of ADMA concentration and reduction of DDAH activity, but not DDAH expression. Captopril can promote the degradation of ADMA through increasing activity of DDAH and improve endothelium function.
What problem does this paper attempt to address?